Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
碩士 === 中國醫藥大學 === 臨床醫學研究所碩士班 === 102 === Till now, advanced lung adenocarcinoma (LAC), is associated with poor survival and few effective therapies are available. Epithelial Growth Factor Receptor (EGFR) mutations are known as oncogene driver mutations and patients with EGFR gain-of-function mutatio...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/8r38d8 |